Integra Lifesciences Holdings Corp (IART) Price Prediction & ForecastIARTIntegra Lifesciences Holdings Corp

Alphio's IART stock price prediction model matches the current Integra Lifesciences Holdings Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.38 (-0.52%). The 1-week path is $13.34 (-0.80%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Integra Lifesciences Holdings Corp (IART) is currently not a strong buy due to its recent performance and analyst downgrades. The current price is $13.21, which is below the adjusted analyst price target of $15. Additionally, the RSI is at 36.99, indicating that the stock is nearing oversold territory but has not yet shown a strong reversal signal. The company has faced challenges, including a significant net income loss of $484 million in Q2 2025, which raises concerns about its profitability moving forward. However, the gross margin remains relatively healthy at 54.90% in Q2 2026, suggesting some operational efficiency. The main risk is the company's high debt-to-equity ratio of 179.45%, which could limit financial flexibility and growth opportunities.

Integra Lifesciences Holdings Corp (IART) last closed at $13.45, gaining +1.82%. These facts feed the 1-day and 1-week IART price prediction above.